Moderna Announces Cancer Vaccine Clinical Results and Stock Surges
MRNA Moderna Inc
$206.80 -3.93%
View chart & analysis → - 1Moderna announced Phase 3 clinical trial results for its Intismeran cancer vaccine on August 19.
- 2Moderna's stock price has risen more than 600% since January, drawing market attention.
- 3Moderna's market capitalization reached approximately $90 billion, a significant increase compared to its market capitalization of less than $12 billion in early 2026.
So what's the key point?
Moderna released results from its cancer vaccine trials. The stock price rose by over 600%, leading to a large increase in the company's value.
Source The Motley Fool +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.